Dr Ravandi-Kashani on the FDA Approval of Luspatercept in MDS

Farhad Ravandi-Kashani, MD, discusses the FDA approval of luspatercept in myelodysplastic syndrome.

Related Keywords

Texas ,United States ,Guillermo Garcia Manero ,Farhad Ravandi Kashani ,Stephena Lasher ,Department Of Leukemia ,Md Anderson Cancer Center ,University Of Texas Md Anderson Cancer Center ,Division Of Cancer Medicine ,Developmental Therapeutics ,Cancer Medicine ,Cancer Center ,Stimulating Agent ,2023 Soho Meeting Reporter ,Onclive Tv ,